BioNTech (BNTX) is down -9.8%, or -$10.20 to $94.11.
Easter Sale - 70% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BNTX:
- Covid vaccine makers drop as WaPo says officials to link shots to child deaths
- Trump officials to link COVID shots to child deaths, WaPo reports
- Positive Outlook for BioNTech SE: Stable Vaccine Business and Growth Catalysts Justify Buy Rating
- Health officials compile data on Covid shots on pregnant women, WSJ says
- Positive Outlook for BioNTech’s BNT327 in Lung Cancer Treatment Justifies Buy Rating